Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis

M Brunström, B Carlberg - JAMA internal medicine, 2018 - jamanetwork.com
Importance High blood pressure (BP) is the most important risk factor for death and
cardiovascular disease (CVD) worldwide. The optimal cutoff for treatment of high BP is …

[HTML][HTML] A'diamond'approach to personalized treatment of angina

R Ferrari, PG Camici, F Crea, N Danchin… - Nature Reviews …, 2018 - nature.com
In clinical guidelines, drugs for symptomatic angina are classified as being first choice (β-
blockers, calcium-channel blockers, short-acting nitrates) or second choice (ivabradine …

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of …

B Ibanez, S James, S Agewall, MJ Antunes… - European heart …, 2018 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

[PDF][PDF] 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

B Ibanez, S James, S Agewall… - Kardiologia Polska …, 2018 - journals.viamedica.pl
Podstawą uaktualnień dotyczących postępowania u pacjentów z zawałem serca z
uniesieniem odcinka ST (STEMI) powinny być rzetelne dowody, pochodzące w miarę …

Treatment of angina: where are we?

C Balla, R Pavasini, R Ferrari - Cardiology, 2018 - karger.com
Ischaemic heart disease is a major cause of death and disability worldwide, while angina
represents its most common symptom. It is estimated that approximately 9 million patients in …

Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14–effects of different classes of antihypertensive drugs in older and younger …

C Thomopoulos, G Parati, A Zanchetti - Journal of hypertension, 2018 - journals.lww.com
Methods: Two databases we had previously identified [72 placebo-controlled BP-lowering
randomized clinical trials (RCTs) in 260 210 individuals and 50 RCTs head-to-head …

Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13–benefits and adverse events in older and younger patients with …

C Thomopoulos, G Parati, A Zanchetti - Journal of hypertension, 2018 - journals.lww.com
Background: There is overwhelming evidence that blood pressure (BP)-lowering treatment
can reduce cardiovascular outcomes also in the elderly, but some important aspects …

Дислипидемии, атеросклероз и ишемическая болезнь сердца: современные аспекты патогенеза, диагностики и лечения

ИВ Сергиенко, АА Аншелес, ВВ Кухарчук - 2018 - elibrary.ru
В третье издание монографии, посвященной атеросклерозу, вошла предыдущая книга
авторов «Атеросклероз и дислипидемии», выпущенная в 2017 г., а также новые главы …

Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis

W Xie, F Zheng, E Evangelou, O Liu, Z Yang… - Journal of …, 2018 - journals.lww.com
Objective: To systematically evaluate the efficacy of five commonly used blood pressure-
lowering drugs in reducing cardiovascular events among patients with nonacute …

Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium

O Borisenko, V Lukyanov, I Debergh… - Journal of medical …, 2018 - Taylor & Francis
Aims: This study presents the cost-effectiveness analysis of bariatric surgery in Belgium from
a third-party payer perspective for a lifetime and 10-year horizon. Materials and methods: A …